Identification of a novel cell cycle‐related gene signature predicting survival in patients with gastric cancer
- 21 September 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (5) , 6350-6360
Abstract
Gastric cancer (GC) is one of the most fatal cancers in the world. Thousands of biomarkers have been explored that might be related to survival and prognosis via database mining. However, the prediction effect of single gene biomarkers is not specific enough. Increasing evidence suggests that gene signatures are emerging as a possible better alternative. We aimed to develop a novel gene signature to improve the prognosis prediction of GC. Using the messenger RNA (mRNA)‐mining approach, we performed mRNA expression profiling in a large GC cohort (n = 375) from The Cancer Genome Atlas (TCGA) database. Gene Set Enrichment Analysis (GSEA) was performed, and we recovered genes related to the G2/M checkpoint, which we identified with a Cox proportional regression model. We identified a set of five genes (MARCKS, CCNF, MAPK14, INCENP, and CHAF1A), which were significantly associated with overall survival (OS) in the test series. Based on this five‐gene signature, the test series patients could be classified into high‐risk or low‐risk subgroups. Multivariate Cox regression analysis indicated that the prognostic power of this five‐gene signature was independent of clinical features. In conclusion, we developed a five‐gene signature related to the cell cycle that can predict survival for GC. Our findings provide novel insight that is useful for understanding cell cycle mechanisms and for identifying patients with GC with poor prognoses.Keywords
Funding Information
- National Natural Science Foundation of China (No. U1608281)
This publication has 33 references indexed in Scilit:
- Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organismBMC Genomics, 2011
- Topoisomerase IIα maintains genomic stability through decatenation G2 checkpoint signalingOncogene, 2010
- What should physicians look for in evaluating prognostic gene-expression signatures?Nature Reviews Clinical Oncology, 2010
- Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancerInternational Journal of Molecular Medicine, 2010
- Topoisomerase IIα controls the decatenation checkpointNature Cell Biology, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Inhibition of DNA Decatenation, but Not DNA Damage, Arrests Cells at MetaphaseMolecular Cell, 2004
- Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing IrradiationMolecular and Cellular Biology, 2001
- Principles of CDK regulationNature, 1995
- A topoisomerase II-dependent G2 cycle checkpoint in mammalian cellsNature, 1994